Affinity Asset Advisors’s Trillium Therapeutics Inc. TRIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-200,000
Closed -$3.51M 83
2021
Q3
$3.51M Buy
+200,000
New +$3.51M 0.89% 24